GCM
IRMD icon

Gladius Capital Management’s iRadimed IRMD Stock Holding History

Gladius Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,727
Closed -$86.9K – 158
2024
Q3 		$86.9K Buy
1,727
+965
+127% +$44.5K 0.01% 129
2024
Q2 		$33.5K Sell
762
-56
-7% -$2.38K ﹤0.01% 201
2024
Q1 		$36K Buy
818
+101
+14% +$4.46K 0.01% 248
2023
Q4 		$34K Sell
717
-92
-11% -$3.87K 0.01% 253
2023
Q3 		$35.9K Buy
+809
New +$37.6K ﹤0.01% 248

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Gladius Capital Management's IRMD Position: Q4 2024 in Review

Gladius Capital Management sold out of iRadimed (IRMD) in Q4 2024, closing a stake of 1,727 shares — an estimated $86.9K sold.

Gladius Capital Management first reported a position in IRMD in Q3 2023 and held it in 5 quarters. The position peaked at $86.9K in Q3 2024. 166 funds tracked by Wall St. Rank hold IRMD as of Q4 2024.

  • Gladius Capital Management reported no remaining iRadimed position as of Q4 2024 after selling out during the quarter.
  • Gladius Capital Management sold 1,727 iRadimed shares in Q4 2024, an estimated $86.9K.
  • Gladius Capital Management first reported a position in iRadimed in Q3 2023 and held it in 5 quarters.
  • Gladius Capital Management's iRadimed position peaked at $86.9K in Q3 2024.
  • 166 funds tracked by Wall St. Rank held iRadimed as of Q4 2024.

Based on Gladius Capital Management's 13F filing for Q4 2024, filed 31 Jan 2025.